Direxion Daily S&P Biotech Bear 3X ETF
LABD
14 hedge funds and large institutions have $45.5M invested in Direxion Daily S&P Biotech Bear 3X ETF in 2019 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 5 increasing their positions, 5 reducing their positions, and 3 closing their positions.
224% more call options, than puts
Call options by funds: $20.2M | Put options by funds: $6.23M
99% more capital invested
Capital invested by funds: $22.8M → $45.5M (+$22.6M)
65.52% more ownership
Funds ownership: 21.27% → 86.79% (+66%)
33% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 3
8% more funds holding
Funds holding: 13 → 14 (+1)
0% more repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 5
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BC
Boxer Capital
San Diego,
California
|
+$51.2M |
| 2 |
IMC Chicago
Chicago,
Illinois
|
+$4.18M |
| 3 |
HF
HRT Financial
New York
|
+$1.47M |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$614K |
| 5 |
VF
Virtu Financial
New York
|
+$479K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
-$6.44M |
| 2 |
Jane Street
New York
|
-$1.51M |
| 3 |
BG
Bellevue Group
Kuesnacht,
Switzerland
|
-$1.39M |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
-$277K |
| 5 |
XS
XR Securities
Chicago,
Illinois
|
-$225K |
LABD Hedge Fund Activity: Q4 2019 in Review
14 of the 5,092 institutional investors tracked by Wall St. Rank reported a position in Direxion Daily S&P Biotech Bear 3X ETF (LABD) for Q4 2019, worth a combined $45.5M — up 99% from $22.8M a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new LABD positions and 3 closed out — a net gain of 1 holder — while 5 added to existing stakes and 5 trimmed.
The largest buyer was Boxer Capital, opening a new position worth an estimated $51.2M. The largest seller was Morgan Stanley, cutting an estimated $6.44M.
- 14 institutional investors held Direxion Daily S&P Biotech Bear 3X ETF (LABD) as of Q4 2019, up from 13 in Q3 2019.
- Funds reported $45.5M of Direxion Daily S&P Biotech Bear 3X ETF stock for Q4 2019, up 99% quarter-over-quarter.
- 4 funds opened new Direxion Daily S&P Biotech Bear 3X ETF positions in Q4 2019 and 3 closed out, a net change of +1 holder.
- The largest Direxion Daily S&P Biotech Bear 3X ETF buyer in Q4 2019 was Boxer Capital, an estimated $51.2M added.
- The largest Direxion Daily S&P Biotech Bear 3X ETF seller in Q4 2019 was Morgan Stanley, an estimated $6.44M sold.
Based on aggregated 13F filings for Q4 2019.